Should the sex of the fetus be considered when administering antenatal corticosteroids to preterm fetuses?

In our study, we have shown that ANS has no effect on mortality in female fetuses younger than 32 weeks. Future studies may focus on adjusting the administration of ANS based on fetal sex, altering the dose or taking fetal sex into account when performing ANS.